文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

MST1 是阿尔茨海默病的一个新的治疗靶点,通过调节线粒体 DNA 转录和 PI3K-Akt-ROS 通路来调节线粒体稳态。

MST1, a novel therapeutic target for Alzheimer's disease, regulates mitochondrial homeostasis by mediating mitochondrial DNA transcription and the PI3K-Akt-ROS pathway.

机构信息

Department of Neurology, The Second Hospital of Shandong University, Shandong University, Jinan, 250033, China.

Department of Neurology, Qilu Hospital of Shandong University, Jinan, 250012, China.

出版信息

J Transl Med. 2024 Nov 22;22(1):1056. doi: 10.1186/s12967-024-05852-x.


DOI:10.1186/s12967-024-05852-x
PMID:39578795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11583452/
Abstract

BACKGROUND: Alzheimer's disease (AD) is a prevalent irreversible neurodegenerative condition marked by gradual cognitive deterioration and neuronal loss. The mammalian Ste20-like kinase (MST1)-Hippo pathway is pivotal in regulating cell apoptosis, immune response, mitochondrial function, and oxidative stress. However, the association between MST1 and mitochondrial function in AD remains unknown. Therefore, this study investigates the effect of MST1 on neuronal damage and cognitive impairment by regulating mitochondrial homeostasis in AD. METHODS: In this study, 4- and 7-month-old 5xFAD mice were selected to simulate the early and middle stages of AD, respectively; age-matched wild-type mice served as controls for comparative analysis. Adeno-associated virus (AAV) was injected into the hippocampus of mice. Four weeks post-injection, cognitive function, neuronal damage indicators, and mitochondrial morphology, dynamics, oxidative stress, ATP, and apoptosis-related indicators were evaluated. Additionally, RNA-sequencing was performed on the hippocampal tissue of 5xFAD mice and MST1-knockdown 5xFAD mice. Subsequently, Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed on differentially expressed genes to elucidate the potential mechanism of MST1. In vitro studies were performed to investigate the effects of MST1 on SH-SY5Y model cell viability and mitochondrial function and validate the potential underlying molecular mechanisms. RESULTS: MST1 overexpression accelerated neuronal degeneration and cognitive deficits in vivo while promoting oxidative stress and mitochondrial damage. Similarly, in vitro, MST1 overexpression facilitated apoptosis and mitochondrial dysfunction. MST1 knockdown and chemical inactivation reduced cognitive decline, mitochondrial dysfunction, and neuronal degeneration. Mechanistically, MST1 regulated the transcription of mitochondrial genes, including MT-ND4L, MT-ATP6, and MT-CO2, by binding to PGC1α. Moreover, MST1 influenced cellular oxidative stress through the PI3K-Akt-ROS pathway, ultimately disrupting mitochondrial homeostasis and mediating cell damage. CONCLUSIONS: Cumulatively, these results suggest that MST1 primarily regulates mitochondrial DNA transcription levels by interacting with PGC1α and modulates cellular oxidative stress through the PI3K-Akt-ROS pathway, disrupting mitochondrial homeostasis. This discovery can be exploited to potentially enhance mitochondrial energy metabolism pathways by targeting MST1, offering novel potential therapeutic targets for treating AD.

摘要

背景:阿尔茨海默病(AD)是一种常见的不可逆神经退行性疾病,其特征是认知能力逐渐下降和神经元丧失。哺乳动物 Ste20 样激酶(MST1)-Hippo 通路在调节细胞凋亡、免疫反应、线粒体功能和氧化应激方面起着关键作用。然而,MST1 与 AD 中线粒体功能之间的关联尚不清楚。因此,本研究通过调节 AD 中线粒体的动态平衡,研究了 MST1 对神经元损伤和认知障碍的影响。

方法:本研究选择 4 月龄和 7 月龄的 5xFAD 小鼠分别模拟 AD 的早期和中期阶段,年龄匹配的野生型小鼠作为对照进行比较分析。将腺相关病毒(AAV)注入小鼠海马体。注射后 4 周,评估认知功能、神经元损伤标志物以及线粒体形态、动力学、氧化应激、ATP 和凋亡相关指标。此外,对 5xFAD 小鼠和 MST1 敲低 5xFAD 小鼠的海马组织进行 RNA 测序。随后,对差异表达基因进行基因本体论(GO)富集和京都基因与基因组百科全书(KEGG)通路分析,以阐明 MST1 的潜在机制。体外研究旨在探讨 MST1 对 SH-SY5Y 模型细胞活力和线粒体功能的影响,并验证潜在的分子机制。

结果:MST1 过表达加速了体内神经元退化和认知缺陷,同时促进了氧化应激和线粒体损伤。同样,在体外,MST1 过表达促进了细胞凋亡和线粒体功能障碍。MST1 敲低和化学失活减少了认知下降、线粒体功能障碍和神经元退化。机制上,MST1 通过与 PGC1α 结合,调节线粒体基因(包括 MT-ND4L、MT-ATP6 和 MT-CO2)的转录。此外,MST1 通过 PI3K-Akt-ROS 通路影响细胞内氧化应激,最终破坏线粒体稳态并介导细胞损伤。

结论:综上所述,这些结果表明,MST1 主要通过与 PGC1α 相互作用来调节线粒体 DNA 转录水平,并通过 PI3K-Akt-ROS 通路调节细胞氧化应激,破坏线粒体稳态。这一发现可用于通过靶向 MST1 增强线粒体能量代谢途径,为治疗 AD 提供新的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/984d57f153fa/12967_2024_5852_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/8416a0a597a5/12967_2024_5852_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/7c031fd7164c/12967_2024_5852_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/d39aa549f728/12967_2024_5852_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/d9baf95e57e4/12967_2024_5852_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/3eac728637e3/12967_2024_5852_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/8826bc370ac4/12967_2024_5852_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/0947624e66f8/12967_2024_5852_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/72cc5d1ac323/12967_2024_5852_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/54927d4a2b22/12967_2024_5852_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/bf8a63a756bd/12967_2024_5852_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/984d57f153fa/12967_2024_5852_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/8416a0a597a5/12967_2024_5852_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/7c031fd7164c/12967_2024_5852_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/d39aa549f728/12967_2024_5852_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/d9baf95e57e4/12967_2024_5852_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/3eac728637e3/12967_2024_5852_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/8826bc370ac4/12967_2024_5852_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/0947624e66f8/12967_2024_5852_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/72cc5d1ac323/12967_2024_5852_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/54927d4a2b22/12967_2024_5852_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/bf8a63a756bd/12967_2024_5852_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5097/11583452/984d57f153fa/12967_2024_5852_Fig11_HTML.jpg

相似文献

[1]
MST1, a novel therapeutic target for Alzheimer's disease, regulates mitochondrial homeostasis by mediating mitochondrial DNA transcription and the PI3K-Akt-ROS pathway.

J Transl Med. 2024-11-22

[2]
MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer's disease.

Prog Neurobiol. 2022-7

[3]
Mammalian STE20-like Kinase 1 Knockdown Attenuates TNFα-Mediated Neurodegenerative Disease by Repressing the JNK Pathway and Mitochondrial Stress.

Neurochem Res. 2019-4-4

[4]
Neuritin improves cognitive impairments in APP/PS1 Alzheimer's disease mice model by mitigating neuronal ferroptosis via PI3K/Akt activation.

Int J Biol Macromol. 2025-4

[5]
Chinese formula Guben-Jiannao Ye alleviates the dysfunction of circadian and sleep rhythms in APP/PS1 mice implicated in activation of the PI3K/AKT/mTOR signaling pathway.

J Ethnopharmacol. 2024-12-5

[6]
Rg1 improves Alzheimer's disease by regulating mitochondrial dynamics mediated by the AMPK/Drp1 signaling pathway.

J Ethnopharmacol. 2025-1-31

[7]
GABAB Receptor-Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer's Disease.

J Alzheimers Dis. 2020

[8]
Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer's disease through inactivating the PI3K/Akt signaling pathway.

J Cell Biochem. 2019-10

[9]
MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer's Disease by modulating Hippo-Wnt signaling crosstalk.

Apoptosis. 2024-10

[10]
Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.

Mol Neurobiol. 2017-11-23

引用本文的文献

[1]
Vagus Nerve Stimulation Attenuates Cognitive Impairment in Traumatic Brain Injury via the mtDNA/cGAS-STING/NLRP3 Inflammasome Axis.

Neurocrit Care. 2025-9-4

[2]
Therapeutic assessment of a novel mitochondrial complex I inhibitor in and models of Alzheimer's disease.

bioRxiv. 2025-3-21

本文引用的文献

[1]
Compromised CD8+ T cell immunity in the aged brain increases severity of neurotropic coronavirus infection and postinfectious cognitive impairment.

Aging Cell. 2025-3

[2]
MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer's Disease by modulating Hippo-Wnt signaling crosstalk.

Apoptosis. 2024-10

[3]
Insight into the pathophysiological advances and molecular mechanisms underlying cerebral stroke: current status.

Mol Biol Rep. 2024-5-11

[4]
The Mst1/2-BNIP3 axis is required for mitophagy induction and neuronal viability under mitochondrial stress.

Exp Mol Med. 2024-3

[5]
Mitochondria in Alzheimer's Disease Pathogenesis.

Life (Basel). 2024-1-30

[6]
Functional genomics and small molecules in mitochondrial neurodevelopmental disorders.

Neurotherapeutics. 2024-1

[7]
Mitochondrial genome editing: strategies, challenges, and applications.

BMB Rep. 2024-1

[8]
Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats.

J Ethnopharmacol. 2024-3-25

[9]
MST1/2 in inflammation and immunity.

Cell Adh Migr. 2023-12

[10]
Neural stem cells promote neuroplasticity: a promising therapeutic strategy for the treatment of Alzheimer's disease.

Neural Regen Res. 2024-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索